rs505922
|
|
Duodenal Ulcer
|
|
0.810 |
GeneticVariation
|
BEFREE |
The T allele of rs2294008 encodes a translation initiation codon upstream of the reported site and changes protein localization from the cytoplasm to the cell surface. rs505922 at ABO was also associated with duodenal ulcer in a recessive model (OR = 1.32; P = 1.15 × 10(-10)).
|
22387998 |
2012 |
rs505922
|
|
Duodenal Ulcer
|
T |
0.810 |
GeneticVariation
|
GWASCAT |
The T allele of rs2294008 encodes a translation initiation codon upstream of the reported site and changes protein localization from the cytoplasm to the cell surface. rs505922 at ABO was also associated with duodenal ulcer in a recessive model (OR = 1.32; P = 1.15 × 10(-10)).
|
22387998 |
2012 |
rs505922
|
|
Duodenal Ulcer
|
T |
0.810 |
GeneticVariation
|
GWASDB |
The T allele of rs2294008 encodes a translation initiation codon upstream of the reported site and changes protein localization from the cytoplasm to the cell surface. rs505922 at ABO was also associated with duodenal ulcer in a recessive model (OR = 1.32; P = 1.15 × 10(-10)).
|
22387998 |
2012 |
rs505922
|
|
von Willebrand's factor (lab test)
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
Genetic Drivers of von Willebrand Factor Levels in an Ischemic Stroke Population and Association With Risk for Recurrent Stroke.
|
28495826 |
2017 |
rs505922
|
|
von Willebrand's factor (lab test)
|
T |
0.800 |
GeneticVariation
|
GWASDB |
Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
|
23381943 |
2013 |
rs505922
|
|
von Willebrand's factor (lab test)
|
T |
0.800 |
GeneticVariation
|
GWASCAT |
Ischemic stroke is associated with the ABO locus: the EuroCLOT study.
|
23381943 |
2013 |
rs505922
|
|
Graves Disease
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
|
23612905 |
2013 |
rs505922
|
|
Graves Disease
|
|
0.800 |
GeneticVariation
|
GWASDB |
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
|
23612905 |
2013 |
rs505922
|
|
Venous Thromboembolism
|
|
0.800 |
GeneticVariation
|
GWASDB |
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
|
22672568 |
2012 |
rs505922
|
|
Venous Thromboembolism
|
C |
0.800 |
GeneticVariation
|
GWASDB |
Genetics of venous thrombosis: insights from a new genome wide association study.
|
21980494 |
2011 |
rs505922
|
|
Venous Thromboembolism
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
Genetics of venous thrombosis: insights from a new genome wide association study.
|
21980494 |
2011 |
rs505922
|
|
Venous Thromboembolism
|
C |
0.800 |
GeneticVariation
|
GWASCAT |
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
|
19278955 |
2009 |
rs505922
|
|
Venous Thromboembolism
|
C |
0.800 |
GeneticVariation
|
GWASDB |
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
|
19278955 |
2009 |
rs505922
|
|
Pancreatic carcinoma
|
C |
0.740 |
GeneticVariation
|
GWASCAT |
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.
|
29422604 |
2018 |
rs505922
|
|
Pancreatic carcinoma
|
|
0.740 |
GeneticVariation
|
GWASCAT |
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
|
26098869 |
2015 |
rs505922
|
|
Malignant neoplasm of pancreas
|
|
0.740 |
GeneticVariation
|
BEFREE |
This study provided evidence of SNP rs505922 C allele as a strong risk factor of cancer susceptibility, specifically for pancreatic cancer.
|
25656610 |
2015 |
rs505922
|
|
Pancreatic carcinoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
This study provided evidence of SNP rs505922 C allele as a strong risk factor of cancer susceptibility, specifically for pancreatic cancer.
|
25656610 |
2015 |
rs505922
|
|
Malignant neoplasm of pancreas
|
|
0.740 |
GeneticVariation
|
BEFREE |
SNP rs505922, located within the first intron of the ABO gene, has been associated with the adenocarcinoma subtype of pancreatic cancer.
|
22642827 |
2012 |
rs505922
|
|
Pancreatic carcinoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
SNP rs505922, located within the first intron of the ABO gene, has been associated with the adenocarcinoma subtype of pancreatic cancer.
|
22642827 |
2012 |
rs505922
|
|
Pancreatic carcinoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
Consistent with earlier reports showing a higher risk of PC for individuals with the non-O blood type, the previously reported protective allele (T) for rs505922 was found to be strongly correlated (r(2) = 0.96) with the O allele.
|
21306478 |
2011 |
rs505922
|
|
Malignant neoplasm of pancreas
|
|
0.740 |
GeneticVariation
|
BEFREE |
Consistent with earlier reports showing a higher risk of PC for individuals with the non-O blood type, the previously reported protective allele (T) for rs505922 was found to be strongly correlated (r(2) = 0.96) with the O allele.
|
21306478 |
2011 |
rs505922
|
|
Pancreatic carcinoma
|
C |
0.740 |
GeneticVariation
|
GWASCAT |
We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28).
|
19648918 |
2009 |
rs505922
|
|
Malignant neoplasm of pancreas
|
C |
0.740 |
GeneticVariation
|
GWASDB |
We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28).
|
19648918 |
2009 |
rs505922
|
|
Malignant neoplasm of pancreas
|
|
0.740 |
GeneticVariation
|
BEFREE |
We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28).
|
19648918 |
2009 |
rs505922
|
|
Pancreatic carcinoma
|
|
0.740 |
GeneticVariation
|
BEFREE |
We identified an association between a locus on 9q34 and pancreatic cancer marked by the SNP rs505922 (combined P = 5.37 x 10(-8); multiplicative per-allele odds ratio 1.20; 95% confidence interval 1.12-1.28).
|
19648918 |
2009 |